Krishna Institute of Medical Sciences Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q1 FY27
- June 16, 2026
- Posted by: Neeraj Pandey
- Category: News
KIMS Rs 693.40 (6 Oct 2026 close). 52-week range Rs 575.80 to Rs 858. Q1 FY27 revenue Rs 1,180 cr, up 35%; profit Rs 41.5 cr, down 47%.
Quick Answer
The Krishna Institute of Medical Sciences share price target for 2026 is Rs 616 to Rs 728, which is between 11 percent below and 5 percent above the last close of Rs 693.40, with bull and bear cases of Rs 950 to Rs 1,064 and Rs 323 to Rs 374. Krishna Institute of Medical Sciences reported Q1 FY27 consolidated revenue up 35.3 percent to Rs 1,179.5 crore and profit down 47 percent to Rs 41.5 crore, with EBITDA margin at 18.9 percent against 22.1 percent. Beds rose to 7,459 and debt fell from Rs 3,250 crore to Rs 2,400 crore after a July repayment, while the stock trades at about 152 times trailing earnings and fell 11 percent in two weeks. No brokerage price target was available on the sources we track as of 6 October 2026, so every range below is a Univest research scenario.
The Krishna Institute of Medical Sciences share price target for 2026 is Rs 616 to Rs 728 in the Univest base case, with the stock at Rs 693.40 at the 6 October 2026 close. That is 19.2 percent below its 52-week high of Rs 858.00 and 20.4 percent above its 52-week low of Rs 575.80, and the stock moved down 1.0 percent over the past year. Krishna Institute of Medical Sciences, or KIMS, runs hospitals in Telangana, Andhra Pradesh, Maharashtra, Kerala and Karnataka. Debt to equity is 1.89 and the company pays no dividend.
Three things changed since the last update: Q1 FY27 results on 3 August showed revenue up 35 percent but profit down 47 percent, a QIP and a Rs 1,100 crore debt repayment cut debt, and the stock slid for two weeks to Rs 693. This Krishna Institute of Medical Sciences stock analysis covers the Krishna Institute of Medical Sciences share price today, the Krishna Institute of Medical Sciences share price target for 2026, 2027 and 2030, the Q1 FY27 numbers, catalysts and risks, key price levels and a Krishna Institute of Medical Sciences buy or sell view.
Click Here – Get Free Investment Predictions
What Is the Krishna Institute of Medical Sciences Share Price Target for 2026?
The 2026 target for Krishna Institute of Medical Sciences shares is Rs 616 to Rs 728 in the Univest base case, which is -11.2% to +5.0% against the last close. The bull case is Rs 950 to Rs 1,064 and the bear case is Rs 323 to Rs 374. No brokerage price target was available on the sources we track as of 6 October 2026, so every range below is a Univest research scenario. Analyst consensus is used as a cross-check, not as the base.
Krishna Institute of Medical Sciences Share Price Target Scenarios: Bull Case, Base Case and Bear Case
| Scenario | FY28E EPS | Target Multiple | Price Target (Rs) | Move vs Rs 693.40 |
|---|---|---|---|---|
| Bull Case | Rs 19 | 50x to 56x | 950 to 1,064 | +37.0% to +53.4% |
| Base Case | Rs 14 | 44x to 52x | 616 to 728 | -11.2% to +5.0% |
| Bear Case | Rs 8.5 | 38x to 44x | 323 to 374 | -53.4% to -46.1% |
FY28 EPS of Rs 14 in the base case compares with trailing EPS of Rs 4.63 and assumes new hospitals mature and interest costs fall by about Rs 1,100 crore of repaid debt. The multiples are high because the market values bed growth, and the stock trades at about 50 times the base estimate. The PE multiple used for each case is shown in the table, and the EPS estimate is a Univest assumption, not company guidance. Those assumptions set the Krishna Institute of Medical Sciences share price target range around the current price.
Krishna Institute of Medical Sciences Company Overview and Share Price Today as of 6 October 2026
Krishna Institute of Medical Sciences share price today is Rs 693.40 on the NSE at the 6 October 2026 close, before the market opens on 7 October. The market capitalisation is Rs 29,482 crore, and the stock trades at 152 times earnings against an industry average of 64 times because profit is depressed by new hospital ramp-up. The Univest base case Krishna Institute of Medical Sciences share price target of Rs 616 to Rs 728 is -11.2% to +5.0% from here. The table below sets out the key numbers behind the Krishna Institute of Medical Sciences share price target.
| Parameter | Value | Context |
|---|---|---|
| NSE Ticker | KIMS | BSE code 543308 |
| Sector | Hospitals | Per Univest sector classification |
| Last Close (NSE) | Rs 693.40 | 6 Oct 2026 close |
| 52-Week High | Rs 858.00 | CMP is 19.2% below |
| 52-Week Low | Rs 575.80 | CMP is 20.4% above |
| 1-Year Return | About -1% | Weekly close Rs 700.6 on 10 Oct 2025 to Rs 693.4 |
| Market Capitalisation | Rs 29,482 crore | Mid cap hospital chain |
| Trailing P/E | About 151.6x | Industry P/E about 64.07x |
| P/B Ratio | About 7.87x | Book value Rs 89.22 per share |
| EPS (TTM) | Rs 4.63 | Trailing twelve months |
| Return on Equity | About 10.7% | Debt to equity 1.89 |
| Dividend Yield | Nil | No dividend |
| 12-Month Target (Base Case) | Rs 616 to Rs 728 | Univest base case |
| Bull Case | Rs 950 to Rs 1,064 | +37.0% to +53.4% |
| Bear Case | Rs 323 to Rs 374 | -53.4% to -46.1% |
How Did Krishna Institute of Medical Sciences Perform in Q1 FY27?
KIMS reported Q1 FY27 consolidated revenue from operations of Rs 1,179.5 crore, up 35.3 percent, and consolidated profit of Rs 41.5 crore, down 47.2 percent from Rs 78.6 crore. EBITDA rose 16 percent to Rs 223.4 crore at a margin of 18.9 percent. Together these Q1 FY27 numbers anchor the Krishna Institute of Medical Sciences share price target.
| Metric | Q1 FY27 | Context |
|---|---|---|
| Consolidated Revenue | Rs 1,179.5 crore | Up 35.3% YoY |
| EBITDA | Rs 223.4 crore | Up 16%; margin 18.9% |
| Consolidated Profit | Rs 41.5 crore | Down 47.2% from Rs 78.6 crore |
| ARPOB | Rs 47,200 | Up 9.7% YoY |
| Occupancy | About 49% | Beds 7,459 against 5,499 a year ago |
| Total Debt | Rs 2,400 crore | Down from Rs 3,250 crore |
The company added 787 beds at Kondapur and 208 at Palakkad in the quarter. Management expects interest relief from the Rs 1,100 crore repayment to lift profit from Q2 FY27, and targets 70 percent occupancy in the Telangana cluster in three to four years. The FY27 outlook from management is the main input for these estimates. These numbers sit behind every range in the scenario table above, so they anchor the Krishna Institute of Medical Sciences share price target.
Why Did KIMS Share Price Fall 11 Percent in Two Weeks?
KIMS shares fell about 11 percent in the weeks of 28 September and 5 October, from about Rs 780 to Rs 693, and are 19 percent below the Rs 858 high of the week of 6 July 2026. No single company announcement was behind the fall.
The stock had rallied 15 percent in the week of 9 February and 6 percent in the week of 11 May as growth was priced in. Profit pressure from new hospitals and a rich multiple left it open to profit taking. The Krishna Institute of Medical Sciences share price target scenarios below account for that move.
Key Catalysts for the Krishna Institute of Medical Sciences Share Price Target in 2026
4 catalysts matter most for the Krishna Institute of Medical Sciences share price target, and sector tailwinds in Hospitals are part of the case. Together they decide whether the base case is reached.
1. Bed Additions
Beds rose to 7,459 from 5,499 a year ago. Kondapur earned Rs 45 crore in July against a Rs 32 to Rs 33 crore monthly average. If it plays out, the Krishna Institute of Medical Sciences share price target moves toward the top of the base range.
2. Lower Interest Cost
A QIP and a Rs 1,100 crore repayment cut debt to Rs 2,400 crore. Management expects profit to improve from Q2. Strength here would support the upper end of the Krishna Institute of Medical Sciences share price target.
3. New Units Turning Profitable
Kannur, Kollam and Nashik turned EBITDA positive. More units reaching breakeven lifts margin. Delivery on this point keeps the Krishna Institute of Medical Sciences share price target on track.
4. ARPOB Growth
ARPOB rose 9.7 percent to Rs 47,200. Better payor mix and empanelment help. Better news here would lift the Krishna Institute of Medical Sciences share price target toward the bull case.
What Are the Key Risks to the Krishna Institute of Medical Sciences Share Price Target?
The main risks are slow occupancy gains, debt, a very high valuation and margin pressure from new hospitals. Each can pull the Krishna Institute of Medical Sciences share price target lower.
Slow Occupancy Gains
Occupancy is about 49 percent and Bengaluru is near 20 percent. Slow ramp-up would delay profit. If it materialises, the Krishna Institute of Medical Sciences share price target would slip toward the bear case.
Debt
Debt to equity is 1.89 even after the repayment. Rising rates would hit profit. This is the main downside risk to the Krishna Institute of Medical Sciences share price target.
Very High Valuation
The stock trades at 152 times trailing earnings and 7.9 times book value. A fall to 38 times FY28 EPS of Rs 8.50 would put the price near Rs 323. A worsening here would cut the Krishna Institute of Medical Sciences share price target toward the low end of the range.
Margin Pressure
EBITDA margin fell to 18.9 percent from 22.1 percent. More new hospitals would add start-up losses. Watch it closely, because it can pull the Krishna Institute of Medical Sciences share price target lower quickly.
Krishna Institute of Medical Sciences Stock Analysis: Support and Resistance Levels for the Share Price Target
Krishna Institute of Medical Sciences stock analysis on weekly charts shows a range of Rs 691 to Rs 819 since mid-September, with the stock at the lower end.
The first support level is Rs 691, the low of the week of 5 October. Below that, Rs 650 to Rs 652 holds the April lows, and Rs 575.80 is the January low.
The first resistance level is Rs 722 to Rs 748, the low of the week of 28 September and the high of the week of 5 October. Above that, Rs 783 is the high of the week of 28 September and Rs 819 marks the high of the weeks of 14 and 21 September. These levels come from weekly price action, are not trade recommendations, and frame the near-term Krishna Institute of Medical Sciences share price target.
Krishna Institute of Medical Sciences Share Price Target 2026, 2027 and 2030: Short, Medium and Long Term
Short-Term Krishna Institute of Medical Sciences Share Price Target (3 to 6 Months)
In the near term the stock is likely to trade between Rs 691 and Rs 748, from the early-October low to the high of the week of 5 October. A close above Rs 748 would put Rs 783 in play, while a weekly close under Rs 691 would put Rs 650 in play. The Q2 FY27 results are the main trigger. This range anchors the near-term Krishna Institute of Medical Sciences share price target.
12-Month and 2027 Krishna Institute of Medical Sciences Share Price Target
The 12-month target price is Rs 616 to Rs 728, valued on 44 to 52 times FY28 EPS of Rs 14. The range across scenarios runs from Rs 323 in the bear case to Rs 1,064 in the bull case.
Long-Term Krishna Institute of Medical Sciences Share Price Target for FY29 to 2030
For FY29 to 2030 the Univest scenario range is Rs 720 to Rs 1,092. This assumes EPS of Rs 20 in FY29 and Rs 26 in FY30 and a multiple of 36 to 42 times. It needs occupancy in new hospitals to rise and interest costs to fall as the QIP proceeds cut debt. This is the long-term Krishna Institute of Medical Sciences share price target in the Univest scenarios.
Bull Case and Bear Case for Krishna Institute of Medical Sciences Share Price Target
Bull Case Rs 950 to Rs 1,064
The bull case of Rs 950 to Rs 1,064 for the Krishna Institute of Medical Sciences share price target needs EPS of Rs 19 and the market to pay 50 to 56 times for it. It is +37.0% to +53.4% from the last close.
Bear Case Rs 323 to Rs 374
The bear case of Rs 323 to Rs 374 for the Krishna Institute of Medical Sciences share price target equals 38 to 44 times FY28 EPS of Rs 8.5 and sits below the Rs 575.8 low. It is -53.4% to -46.1% from the last close.
Is Krishna Institute of Medical Sciences a Good Buy at Rs 693? Krishna Institute of Medical Sciences Buy or Sell View
Whether Krishna Institute of Medical Sciences is a buy at Rs 693.40 depends on horizon and risk appetite. The base case sits between 11 percent below and 5 percent above the current price, the stock is 19 percent below its high, and the open question is how fast profit recovers. The Krishna Institute of Medical Sciences share price target range is the starting point for that decision.
Long-term holders may focus on occupancy, interest cost and ARPOB, and treat Rs 691 as the level to watch. Short-term traders may prefer to wait for a close above Rs 748. Check institutional holding in the September quarter filing for signs of accumulation or selling. Consult a SEBI-registered advisor before acting, since this Krishna Institute of Medical Sciences buy or sell view is educational.
How to Invest in Krishna Institute of Medical Sciences Shares
Step 1: Check the live price, valuation and the latest Krishna Institute of Medical Sciences share price target range on the Univest Screener.
Step 2: Open a demat and trading account with a SEBI-registered broker such as Univest before acting on any Krishna Institute of Medical Sciences share price target.
Step 3: Search for KIMS on the NSE or 543308 on the BSE in your trading app.
Step 4: Place a limit order near your planned entry and size the position so a fall to Rs 323 is bearable.
Step 5: Track occupancy, interest cost and Q2 FY27 results and set price alerts on the Univest App to follow any change in the Krishna Institute of Medical Sciences share price target.
Conclusion
Krishna Institute of Medical Sciences closed at Rs 693.40 against a Univest base case share price target of Rs 616 to Rs 728, a bull case of Rs 950 to Rs 1,064 and a bear case of Rs 323 to Rs 374. Q1 FY27 delivered revenue growth of 35 percent but profit down 47 percent, with 7,459 beds and lower debt. The main risks are slow occupancy gains, debt and valuation.
The stock is 19.2 percent below its 52-week high, so the base case sits between 11 percent below and 5 percent above the current price. The triggers to watch are occupancy, interest cost and Q2 FY27 results and the Rs 691 and Rs 748 levels. Re-check the Krishna Institute of Medical Sciences share price target after each quarterly result. Investors with a long horizon and tolerance for volatility can track these triggers, while others may prefer to size positions carefully.
Download the Univest iOS App or Univest Android App to track Krishna Institute of Medical Sciences live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Krishna Institute of Medical Sciences Share Price Target 2026
What is the Krishna Institute of Medical Sciences share price target for 2026?
Ans. The Krishna Institute of Medical Sciences share price target for 2026 is Rs 616 to Rs 728 in the Univest base case, with a bull case of Rs 950 to Rs 1,064 and a bear case of Rs 323 to Rs 374. No brokerage target was available on the sources we track as of 6 October 2026, so these are Univest research scenarios. These are estimates and can change after the Q2 FY27 results.
What is the Krishna Institute of Medical Sciences share price target for 2027?
Ans. The Krishna Institute of Medical Sciences share price target for 2027 is Rs 616 to Rs 728 in the base case, valued on 44 to 52 times FY28 EPS of Rs 14. The scenario range runs from Rs 323 to Rs 1,064.
Is Krishna Institute of Medical Sciences a good buy at Rs 693.40?
Ans. Whether Krishna Institute of Medical Sciences is a good buy at Rs 693.40 depends on your horizon, risk appetite and how you read the Krishna Institute of Medical Sciences share price target. Revenue is growing 35 percent and debt has fallen, but profit is down 47 percent and the stock trades at a very high multiple. Consult a SEBI-registered advisor before investing.
What are the key risks to the Krishna Institute of Medical Sciences share price target?
Ans. The key risks to the Krishna Institute of Medical Sciences share price target are slow occupancy gains, debt, very high valuation and margin pressure. Occupancy is about 49 percent and Bengaluru is near 20 percent. Slow ramp-up would delay profit.
What are the key catalysts for the Krishna Institute of Medical Sciences share price target?
Ans. The key catalysts for the Krishna Institute of Medical Sciences share price target are bed additions, lower interest cost, new units turning profitable and arpob growth. Beds rose to 7,459 from 5,499 a year ago. Kondapur earned Rs 45 crore in July against a Rs 32 to Rs 33 crore monthly average.
Where can I track Krishna Institute of Medical Sciences share price today and Krishna Institute of Medical Sciences share price target updates?
Ans. You can track the live Krishna Institute of Medical Sciences share price, results and any change to the Krishna Institute of Medical Sciences share price target on the Univest Screener and the Univest App. Download the Univest iOS App or Univest Android App for research from SEBI-registered analysts.
What are Krishna Institute of Medical Sciences’s 52-week high and low?
Ans. Krishna Institute of Medical Sciences’s 52-week high is Rs 858.00 and its 52-week low is Rs 575.80, based on weekly NSE data. At Rs 693.40 the stock is 19.2 percent below the high and 20.4 percent above the low. Both levels frame the Krishna Institute of Medical Sciences share price target.
How to buy Krishna Institute of Medical Sciences shares?
Ans. Open a demat account with a SEBI-registered broker such as Univest, search for KIMS on the NSE or 543308 on the BSE, and place a limit order near your entry price, using the Krishna Institute of Medical Sciences share price target range as a guide. Size the position so a fall to Rs 323 is bearable, and check the live price on the Univest Screener first.